Short Title:
Motion Sickness CM Validation - ISS
Responsible HRP Element:
Human Health Countermeasures
|
Collaborating Org(s):
|
| Research Operations and Integration (ROI) |
|
Funding Status:
Planned-Funded - Task expected to be within budget
|
Procurement Mechanism(s):
|
|
Aims:
The aims of this study are two-fold. The first phase will be to better characterize motion sickness and what operational countermeasures are employed during ISS missions. Adaptation to altered gravity will be measured using a 3Gx hypergravity analog either before or after this ISS mission. The second phase will build on a Motion Sickness Countermeasure Development - Ground study and perform the required validation during actual spaceflight.
NOTE: Larger sample size (n=30) required for characterization and variability in landing scenarios, e.g. 15 water and 15 land landings.
Category:
Countermeasure
Subcategory:
Clinical Procedure/Prescription
Description:
This task will contribute to gap closure by testing: A methodology for measuring an individual’s capacity to adapt to an altered gravity environment using affordable centrifuge tests with long duration crewmembers.
This task will contribute to gap closure by testing combined pharmacological with non-pharmaceutical intervention (e.g., pre-adaptation training, sensory augmentation) to reduce the severity of motion sickness and sensorimotor impairment during gravitational transitions with long duration crewmembers. Post—landing surveys will be used to capture what is being used operationally as well as qualitative reports of effectiveness.
Internal Customers:
None
External Customers:
None